Steven Dabbs

996 citations

20 papers · 700 · h-index 13

Impact in

Cellular and Molecular Neuroscience top 5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Organic Chemistry top 10%
- Synthesis and Biological Evaluation

Papers in

Molecular Biology 14
- Receptor Mechanisms and Signaling 6
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Cancer therapeutics and mechanisms 3
- Pharmacological Receptor Mechanisms and Effects 3
Organic Chemistry 13
- Synthesis and Biological Evaluation 4
- Cyclopropane Reaction Mechanisms 3
- Chemical synthesis and alkaloids 3

Co-authors: Frank D. King (7 shared papers)Graham J. Riley (9 shared papers)Ian T. Forbes (7 shared papers)D. Malcolm Duckworth (7 shared papers)Steven M. Bromidge (8 shared papers)Derek N. Middlemiss (3 shared papers)David R. Thomas (2 shared papers)Peter J. Lovell (2 shared papers)
Journals: Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Tetrahedron Letters (3 papers)Bioorganic & Medicinal Chemistry (1 paper)Tetrahedron (1 paper)
Partner nations: United States United Kingdom Spain

In The Last Decade

Steven Dabbs

20 papers receiving 659 citations

Peers

Countries citing papers authored by Steven Dabbs

Since Specialization

Citations

This map shows the geographic impact of Steven Dabbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Dabbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Dabbs more than expected).

Fields of papers citing papers by Steven Dabbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Dabbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Dabbs. The network helps show where Steven Dabbs may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Dabbs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Dabbs Line = papers co-authored together Steven Dabbs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Novel, Potent, and Selective 5-HT₇Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970) Journal of Medicinal Chemistry ·Peter J. Lovell, Steven M. Bromidge, Steven Dabbs, D. Malcolm Duckworth, Ian T. Forbes, A.J. Jennings, Frank D. King, Derek N. Middlemiss, Shirley K. Rahman, Damian V. Saunders, Lissa L. Collin, Jim J. Hagan, Graham J. Riley, David R. Thomas	2000	231
2	(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT₇Receptor Antagonist Journal of Medicinal Chemistry ·Ian T. Forbes, Steven Dabbs, D. Malcolm Duckworth, A.J. Jennings, Frank D. King, Peter J. Lovell, Anthony M. Brown, Lissa L. Collin, Jim J. Hagan, Derek N. Middlemiss, Graham J. Riley, David R. Thomas, Neil Upton	1998	94
3	Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines Journal of Medicinal Chemistry ·Steven M. Bromidge, Steven Dabbs, David T. Davies, D. Malcolm Duckworth, Ian T. Forbes, P. J. Ham, Graham E. Jones, Frank D. King, Damian V. Saunders, Susannah Starr, Kevin M. Thewlis, Paul Wyman, Frank E. Blaney, Christopher Naylor, Fiona P. Bailey, Thomas P. Blackburn, Vicky Holland, G.A. Kennett, Graham J. Riley, Martyn Wood	1998	56
4	5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides Journal of Medicinal Chemistry ·José Luis Bermúdez, Steven Dabbs, Karen A. Joiner, Frank D. King	1990	55
5	Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases Bioorganic & Medicinal Chemistry Letters ·Timothy J. Miles, Alan J. Hennessy, B.D. Bax, Gerald Brooks, Barry S. Brown, Pamela Brown, Nathalie Cailleau, Dongzhao Chen, Steven Dabbs, David T. Davies, Joel M. Esken, Ilaria Giordano, Jennifer L. Hoover, Graham E. Jones, Senthill K. Kusalakumari Sukmar, Roger E. Markwell, Elisabeth A. Minthorn, Steve Rittenhouse, Michael N. Gwynn, Neil D. Pearson	2016	36
6	Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases Bioorganic & Medicinal Chemistry Letters ·Timothy J. Miles, Christopher W. Barfoot, Gerald Brooks, Pamela Brown, Dongzhao Chen, Steven Dabbs, David T. Davies, David L. Downie, Susanne Eyrisch, Ilaria Giordano, Michael N. Gwynn, Alan J. Hennessy, Jennifer L. Hoover, Jianzhong Huang, Graham E. Jones, Roger E. Markwell, Stephen Rittenhouse, Hong Xiang, Neil D. Pearson	2011	33
7	Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists Journal of Medicinal Chemistry ·Ian T. Forbes, Steven Dabbs, D. Malcolm Duckworth, P. J. Ham, Graham E. Jones, Frank D. King, Damian V. Saunders, Frank E. Blaney, Christopher Naylor, Gordon S. Baxter, Thomas P. Blackburn, G.A. Kennett, Martyn Wood	1996	27
8	Design of [R-(Z)]-(+)-α-(Methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a Functionally Selective Azabicyclic Muscarinic M1 Agonist Incorporating the N-Methoxy Imidoyl Nitrile Group as a Novel Ester Bioisostere Journal of Medicinal Chemistry ·Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael Clark, Steven Dabbs, Michael S. Hadley, Julie A. Hawkins, Julia M. Loudon, Christopher Naylor, Barry S. Orlek, Graham J. Riley	1997	26
9	Benzotriazinones as virtual-ring mimics of o-methoxybenzamides: novel and potent 5-HT3 receptor antagonists Journal of Medicinal Chemistry ·F. D. KING, Steven Dabbs, José Luis Bermúdez, Gareth J. Sanger	1990	24
10	Flexible palladium-catalysed amidation reactions for the synthesis of complex aryl amides Tetrahedron Letters ·Christopher W. Barfoot, Gerald Brooks, Pamela Brown, Steven Dabbs, David T. Davies, Ilaria Giordano, Alan J. Hennessy, Graham E. Jones, Roger E. Markwell, Timothy J. Miles, Neil D. Pearson, Christian A. Smethurst	2010	20
11	A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael Clark, Steven Dabbs, Julie A. Hawkins, Julia M. Loudon, Barry S. Orlek, Graham J. Riley	1992	17
12	1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Steven Dabbs, Susannah Davies, D. Malcolm Duckworth, Ian T. Forbes, Graham E. Jones, Jerome Jones, Frank D. King, Damian V. Saunders, Thomas P. Blackburn, Vicky Holland, G.A. Kennett, Sean Lightowler, Derek N. Middlemiss, Graham J. Riley, Brenda Trail, Martyn Wood	2000	16
13	5-Hydroxytryptamine (5-HT3) receptor antagonists. 3. Ortho-substituted phenylureas Journal of Medicinal Chemistry ·José Luis Bermúdez, Steven Dabbs, F. D. KING	1990	15
14	The design of efficient and selective routes to pyridyl analogues of 3-oxo-3,4-dihydro-2H-1,4-(benzothiazine or benzoxazine)-6-carbaldehydes Tetrahedron Letters ·Gerald Brooks, Steven Dabbs, David T. Davies, Alan J. Hennessy, Graham E. Jones, Roger E. Markwell, Timothy J. Miles, Nathan A. Owston, Neil D. Pearson, Tony W. Peng	2010	11
15	The design of efficient and selective routes to pyridyl analogues of 2,3-dihydro-1,4-benzodioxin-6-carbaldehyde Tetrahedron Letters ·Christopher W. Barfoot, Pamela Brown, Steven Dabbs, David T. Davies, Alan J. Hennessy, Timothy J. Miles, Neil D. Pearson	2010	11
16	Pseudohalogen chemistry. XI. Some aspects of the chemistry of α-thiocyanato-β-dicarbonyl compounds Tetrahedron ·Elaine F. Atkins, Steven Dabbs, R. G. Guy, Akbar A. Mahomed, Philip Mountford	1994	10
17	Design and synthesis of azabicyclic muscarinic agonists incorporating an oxime ether functionality Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael Clark, Steven Dabbs, Michael S. Hadley, Julia M. Loudon, Barry S. Orlek, Graham J. Riley	1992	9
18	Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists Bioorganic & Medicinal Chemistry ·Steven M. Bromidge, Steven Dabbs, David T. Davies, Susannah Davies, D. Malcolm Duckworth, Ian T. Forbes, Angela Gadre, P. J. Ham, Graham E. Jones, F. D. KING, Damian V. Saunders, Kevin M. Thewlis, (unknown), Thomas P. Blackburn, Vicky Holland, G.A. Kennett, Graham J. Riley, Martyn Wood	1999	5
19	1,2,5,6-tetrahydropyridine oxime ethers incorporating electron withdrawing groups are potent and selective muscarinic agonists Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge, Frank Brown, Frederick Cassidy, Michael Clark, Emma J. Collings, Steven Dabbs, Richard E. Faulkner, Julia M. Loudon, Barry S. Orlek, Graham J. Riley	1994	3
20	ChemInform Abstract: Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5‐HT2C/2B Receptor Antagonists. ChemInform ·Ian T. Forbes, Steven Dabbs, D. Malcolm Duckworth, P. J. Ham, Gareth E. Jones, Frank D. King, Damian V. Saunders, Frank E. Blaney, Christopher Naylor, Gordon S. Baxter, Thomas P. Blackburn, G.A. Kennett, Martyn Wood	1997	1

About Steven Dabbs

Steven Dabbs is a scholar working on Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience, Molecular Medicine and Pharmacology, having authored 20 papers that have together received 700 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Synthesis and Biological Evaluation (4 papers), Cyclopropane Reaction Mechanisms (3 papers), Cancer therapeutics and mechanisms (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Chemical synthesis and alkaloids (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (279 citations), Organic Chemistry (257 citations), Toxicology (25 citations), Molecular Medicine (35 citations) and Molecular Biology (409 citations). Steven Dabbs has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Frank D. King, Graham J. Riley, Ian T. Forbes, D. Malcolm Duckworth, Steven M. Bromidge, Derek N. Middlemiss, David R. Thomas, Peter J. Lovell, Jim J. Hagan and A.J. Jennings. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Bioorganic & Medicinal Chemistry and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Steven Dabbs

Impact in

Papers in i

In The Last Decade

Steven Dabbs

Peers

Countries citing papers authored by Steven Dabbs

Fields of papers citing papers by Steven Dabbs

All Works

About Steven Dabbs

Explore authors with similar magnitude of impact

Papers in